The transmembrane receptor Notch, a master developmental regulator, controls gliogenesis, neurogenesis, and neurite development in the nervous system. Estradiol, acting as a hormonal signal or as a neurosteroid, also regulates these developmental processes. Here we review recent evidence indicating that estradiol and Notch signaling interact in developing hippocampal neurons by a mechanism involving the putative membrane receptor G protein-coupled receptor 30. This interaction is relevant for the control of neuronal differentiation, since the downregulation of Notch signaling by estradiol results in the upregulation of neurogenin 3, which in turn promotes dendritogenesis.
INTRODUCTION: DEVELOPMENTAL ACTIONS OF ESTRADIOL
Estradiol is a neuroactive steroid that exerts hormonal as well as local paracrine or autocrine actions in the central nervous system, during development and in adulthood. Estradiol is produced in the ovary and in other tissues by the enzyme aromatase, which, in the brain, is expressed by specific neuronal populations (Roselli et al., 2009; Azcoitia et al., 2011) . Brain aromatase and local estradiol synthesis participate in the regulation of brain development. For instance, aromatase is expressed by neural progenitor cells in vertebrates (Mouriec et al., 2008) and it is involved in the regulation of neural progenitor cell proliferation in the embryonic cerebral cortex of mice (Martinez-Cerdeno et al., 2006) . In addition, many of the developmental effects of hormonal testosterone on male brain sexual differentiation are mediated by its local conversion to estradiol by neurons expressing the enzyme aromatase (MacLusky and Naftolin, 1981; Roselli et al., 2009) . Furthermore, recent evidence indicate that estradiol also participates in the regulation of brain sexual differentiation in females (Bakker and Brock, 2010; Brock et al., 2011) .
In addition to regulate the proliferation of neural progenitor cells (Martinez-Cerdeno et al., 2006) , estradiol modulates the development of postmitotic neurons, affecting the growth of axons, dendrites and dendritic spines, and the formation of synapses (Ferreira and Caceres, 1991; Díaz et al., 1992; Duenas et al., 1996; Beyer and Karolczak, 2000; Woolley, 2000; Blacklock et al., 2005; Tsutsui, 2006; Miñano et al., 2008; Bender et al., 2010) . These developmental actions depend in many cases of local estradiol synthesis (Kretz et al., 2004; Tsutsui, 2006; von Schassen et al., 2006; Hu et al., 2007; Sasahara et al., 2007) .
NOTCH SIGNALING IN NEURAL DEVELOPMENT
Notch is a transmembrane receptor involved in cell to cell communication. The activation of Notch by transmembrane ligands, Delta-like, and Jagged, results in the cleavage of the molecule and the release of a Notch intracellular domain that is translocated to the cell nucleus and regulates transcriptional activity (Lai, 2004) . Notch signaling controls cell-fate specification, differentiation, proliferation, and apoptosis in developing tissues (ArtavanisTsakonas et al., 1999) . In the nervous system, Notch signaling regulates neurogenesis and gliogenesis, not only during development but also in the adult brain (Louvi and Artavanis-Tsakonas, 2006; Ables et al., 2011; Pierfelice et al., 2011) . In developing neurons, Notch signaling inhibits neurite outgrowth. In contrast, the inhibition of Notch signaling promotes neurite extension (Berezovska et al., 1999; Sestan et al., 1999; Salama-Cohen et al., 2005) .
The activation of Notch signaling in developing hippocampal neurons in vitro (Figure 1 ) is associated with an increase in the expression of the transcription factors hairy and enhancer of split (Hes) 1 and 5 (Salama-Cohen et al., 2005) . Hes transcription factors regulate the expression of several genes involved in cell differentiation. One of such genes is the basic helix-loop-helix transcription factor neurogenin 3 (Ngn3), which in developing pancreas is a proendocrine gene that causes the differentiation of the four endocrine cell lineages (Lee et al., 2001; Rukstalis and Habener, 2009 ) and that it is downregulated by Notch signaling via Hes1 (Lee et al., 2001) . Activation of Notch signaling in neurons also induces a decrease in the expression of Ngn3 (Salama-Cohen et al., 2006) . Ngn3 participates in different developmental events in the central nervous system. In the developing spinal cord, Ngn3 is expressed in glial precursor cells and it is necessary for the normal differentiation of mature oligodendrocytes and astrocytes (Lee et al., 2003) . In chick embryos, Ngn3 promotes early retinal neurogenesis (Ma et al., 2009 ). In the hypothalamus, Ngn3 regulates the differentiation of several neuronal populations, including proopiomelanocortin (POMC) and neuropetide Y (NPY) neurons, which play a central role in energy balance and the control of food intake www.frontiersin.org Pelling et al., 2011) . In hippocampal neurons, Ngn3 promotes the growth of dendrites and regulates the number of afferent GABAergic synaptic inputs (Salama-Cohen et al., 2006) . Therefore, the activation of Notch in developing hippocampal neurons represses the process of dendritogenesis by the downregulation of Ngn3 (Figure 1) .
CROSS-TALK BETWEEN ESTRADIOL AND NOTCH SIGNALING
Cross-talk between estradiol and Notch signaling has been detected in breast cancer cells and endothelial cells (Soares et al., 2004; Sobrino et al., 2009 ). Furthermore, the estrogenic compound genistein downregulates Notch-1 in prostate cancer cells (Wang et al., 2006 (Wang et al., , 2011 . In breast cancer cells, estradiol decreases Notch transcriptional activity via an estrogen receptor (ER) α-mediated inhibition of Notch cleavage by γ-secretase (Rizzo et al., 2008) . In turn, Notch-1 activates ERα-dependent transcription in these cells in the presence or absence of estradiol (Hao et al., 2010) . Therefore, estradiol regulates Notch signaling and Notch signaling regulates estrogen signaling in breast cancer cells. It remains to be determined whether the cross-regulation of estrogen and Notch signaling also occurs in other cell types. Given the importance of Notch signaling for brain development, it is important to explore whether such interaction takes place in neural cells.
Recent studies have shown that estradiol reduces the levels of the intracellular transcriptionally active domain of Notch-1 in hippocampal slice cultures (Bender et al., 2010) . This suggests that estradiol may decrease Notch-1 mediated transcription in hippocampal cells by reducing Notch-1 cleavage (Figure 2) . In primary cultures of mice hippocampal neurons, estradiol decreases the expression of Hes1 and increases the expression of Ngn3 (Ruiz-Palmero et al., 2011) . These findings further indicate that estradiol downregulates Notch signaling in hippocampal neurons (Figure 2) . G protein-coupled receptor 30 (GPR30), also known as G protein-coupled estrogen receptor (GPER), is a putative membrane associated ER (Prossnitz et al., 2008; Olde and LeebLundberg, 2009; Prossnitz and Maggiolini, 2009; Langer et al., 2010) . GPR30 seems to be involved in the regulation of Notch signaling in hippocampal neurons, since G1, a ligand of GPR30 that imitates the effects of estradiol in different cell types and tissues (Terasawa et al., 2009; Zhang et al., 2010 ) also imitates the effect of estradiol on Ngn3 expression in hippocampal neurons (Ruiz-Palmero et al., 2011) . In contrast, neither the ERα agonist 4,4 ,4 -(4-Propyl-[1H ]-pyrazole-1,3,5-triyl) trisphenol (PPT) nor the ERβ agonist 2,3-bis (4-Hydroxyphenyl)-propionitrile (DPN) affect the expression of Ngn3 in hippocampal neurons (Ruiz-Palmero et al., 2011). In addition, 1,3-Bis (4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy) phenol]-1H -pyrazole (MPP) and 4-[2-Phenyl-5,7-bis (trifluoromethyl) pyrazolo [1,5-a] pyrimidin-3-yl] phenol (PHTPP), selective antagonists of ERα and ERβ mediated transcription, respectively, do not antagonize the effect of estradiol on Ngn3 expression (Ruiz-Palmero et al., 2011). Furthermore, ICI 182,780 (ICI) , antagonist of both ERα and ERβ mediated transcription and agonist of GPR30 (Thomas et al., 2005) , not only does not block, but even imitates, the effect of estradiol on Ngn3 expression (Ruiz-Palmero et al., 2011) . Therefore, estradiol may regulate Ngn3 levels in hippocampal neurons by a non-canonical mechanism, which probably is independent of classical nuclear ER mediated transcription.
ESTRADIOL PROMOTES DENDRITOGENESIS IN HIPPOCAMPAL NEURONS BY A MECHANISM INVOLVING Ngn3
The neuritogenic action of estradiol is mediated by the activation of the mitogen activated protein kinase (MAPK) cascade among other signaling mechanisms (Carrer et al., 2003 (Carrer et al., , 2005 Dominguez et al., 2004; Gorosito and Cambiasso, 2008; Miñano et al., 2008) . Recent studies have assessed whether Notch signaling is also involved in the neuritogenic actions of estradiol. Estradiol promotes dendritogenesis in primary hippocampal neurons in culture; this effect is imitated by G1 and it is not blocked by ICI (Ruiz-Palmero et al., 2011) . Furthermore, neither G1 nor estradiol promote dendritogenesis in hippocampal neurons when Ngn3 is downregulated using Ngn3-specific siRNA oligonucleotides (Ruiz-Palmero et al., 2011) . Therefore estradiol and G1 may act through common mechanisms to regulate Ngn3 expression and dendritogenesis by the inhibition of Notch signaling (Figure 2) .
CONCLUSION
The studies reviewed here indicate that estradiol interacts with Notch signaling in the nervous system. Estradiol regulates dendritogenesis in developing hippocampal neurons through the modulation of Notch signaling and the upregulation of Ngn3 by a mechanism involving the putative membrane ER GPR30. Further studies are necessary to determine whether this mechanism also operates in other neuronal types. In addition, new experiments are needed to clarify the molecular mechanisms linking estrogen/GPR30 and Notch signaling in neurons.
